Type | Description |
---|---|
Definition | cereblon |
Date | Results | Publications |
---|---|---|
2021-03-27 14:44:00 | Role of cereblon in angiogenesis and in mediating the antiangiogenic activity of immunomodulatory drugs. | 32677118 |
2021-03-06 13:32:00 | CUL4-DDB1-CRBN E3 Ubiquitin Ligase Regulates Proteostasis of ClC-2 Chloride Channels: Implication for Aldosteronism and Leukodystrophy. | 32466489 |
2021-02-13 13:29:00 | Aromatase is a novel neosubstrate of cereblon responsible for immunomodulatory drug-induced thrombocytopenia. | 32219443 |
2021-02-06 13:59:00 | Cereblon Promotes the Ubiquitination and Proteasomal Degradation of Interleukin Enhancer-Binding Factor 2. | 33009960 |
2020-12-05 13:04:00 | CRL4-Cereblon complex in Thalidomide Embryopathy: a translational investigation. | 31964914 |
Type | IDs |
---|---|
Synonymous | MRT2, MRT2A |
Gene |
UniProtKB-ID:
CRBN_HUMAN
UniprotKB:
Q96SW2
UniParc:
UPI000006E62A,
UPI000058E4BD
EMBL:
BC017419,
BC067811,
AC024060,
AF117230,
CR627060,
AK312577,
AK027507
Ensembl:
ENSG00000113851
KO:
hsa:51185
|
Nucleutide sequences |
EMBL-CDS:
CAH10361.1,
AAF17211.1,
BAG35471.1,
AAH17419.1,
AAH67811.1,
BAB55162.1
Gene_ORFName:
AD-006
Ensembl_TRS:
ENST00000231948,
ENST00000432408
|
Protein sequencees |
Ensembl_PRO:
ENSP00000231948,
ENSP00000412499
RefSeq:
XP_011532095.1,
XP_005265259.1,
NP_001166953.1,
XP_011532096.1,
XP_011532093.1,
XP_024309319.1,
NP_057386.2
|
Others |
UniRef100:
UniRef100_Q96SW2
UniRef90:
UniRef90_Q96SW2
UniRef50:
UniRef50_Q96SW2
UniGene:
Hs.18925
CCDS:
CCDS54547.1,
CCDS2562.1
|
{{proteinIndex+1}} | mRNA | Protein | UniprotKB | Description | ||||
---|---|---|---|---|---|---|---|---|
Refseq |
{{protein.nucleotideVersion}}
Ensembl: {{protein.nucleotideEnsembl}} |
{{protein.proteinVersion}}
Ensembl: {{protein.proteinEnsembl}} |
{{uniprot}} , |
Definition: {{{protein.definition}}}Transcript Veriant:{{protein.transcriptVeriant}} Status: {{protein.status}} |
||||
Location | {{protein.contigId}} ( {{protein.positionStart}}..{{protein.positionEnd}} , {{protein.orientation}} ) | |||||||
Conserved domain | Region: {{conservedDomain.region == '' || conservedDomain.region == null ? "-": conservedDomain.region}} GFID: {{conservedDomain.gfid == '' || conservedDomain.gfid == null ? "-": conservedDomain.gfid}} Family: {{conservedDomain.family == '' || conservedDomain.family == null ? "-": conservedDomain.family}} CDD: {{conservedDomain.cdd}} - |
{{conservedDomain.comments == '' || conservedDomain.comments == null ? "-" : conservedDomain.comments }} |
Region: {{conservedDomain.region == '' || conservedDomain.region == null ? "-": conservedDomain.region}} GFID: {{conservedDomain.gfid == '' || conservedDomain.gfid == null ? "-": conservedDomain.gfid}} Family: {{conservedDomain.family == '' || conservedDomain.family == null ? "-": conservedDomain.family}} CDD: {{conservedDomain.cdd}} - |
{{conservedDomain.comments == '' || conservedDomain.comments == null ? "-" : conservedDomain.comments }} |
暂无数据
排名 | 科研单位 | 文献 |
---|---|---|
{{affIndex+1}} |
{{aff.value}} |
{{aff.size}} |
目前还没有研究热点单位
排名 | 研究人员 | 文献 |
---|---|---|
{{authorIndex+1}} |
{{author.value}} |
{{author.size}} |
目前还没有研究热点人员